Thankful to have received the Inaugural Early Career Clinician Scientist research award @StJude@LeBonheurChild along with my friends @JasonGoldbergMD@HugoMartinezMD 😀 We are all working towards improving outcomes for our patients 🫘 ❤️
Congrats Dr. JS Hankins and KI Ataga on your recent publication! Enuresis and Hyperfiltration in Children with Sickle Cell Disease. https://t.co/nAN7hne7uW Zahr RS, Ding J, Kang G, Wang WC, Hankins JS, Ataga KI, Lebensburger JD, Porter JS; J Pediatr Hematol Oncol. 2022 Feb 18.
Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study
https://t.co/szKFYrgERO
@HeatherWasik@funsocdoc#lupus#dialysis#pedneph
Attending @PASMeeting? Check out @drRimaZahr's poster for her @NAPRTCS1 Special Study "Characterization of CKD and Dialysis in Children with Sickle Cell Kidney Disease in the NAPRTCS registry" with Sushil Gupta at @IUPedsKidney@ASPNeph
Join our nephrology team @PASMeeting@arwanadaa presenting new innovative way of diagnosing neonatal AKI 5/1 at 4:30 CT & @xoamcari (SPR clinical research awardee) presenting our data on kidney involvement in children with SARS-CoV2 infection 6:15-7:15 @ASPNeph@LeBonheurChild
Hemodialysis (HD) dose targets & ultrafiltration rate (UFR) limits for pediatric patients on chronic HD are not known and are derived from adults (spKt/V>1.4 & <13 ml/kg/h). For best long-term outcomes read more here:
https://t.co/jpCLi16X8n